Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 23, 2025, titled "Zydus receives final approval from USFDA for Isotretinoin Capsules USP, 10 mg 20 mg, 25 mg, 30 mg, 35 mg and 40 mg".
Press Release May 23 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release May 20 2025
- Press Release May 14 2025
- Press Release May 08 2025
- Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
- Press Release Apr 30 2025
Later from Zydus Lifesciences
- Press Release May 28 2025
- Zydus Lifesciences Limited Press Release Jun 02 2025
- Press Release Jun 10 2025
- Press Release Jun 11 2025
- Press Release Jun 18 2025
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences